Giriraj Singh hails India's COVID vaccine prowess and global outreach
Synopsis
Union Textiles Minister Giriraj Singh praised India's COVID-19 pandemic response, citing indigenous vaccine development and the Vaccine Maitri export initiative as evidence of the country's scientific capability and self-reliance under strong national leadership.
Key Takeaways
Giriraj Singh posted on September 29, 2026 , celebrating India's COVID-19 vaccine achievement and international supply efforts.
India granted emergency use authorisation for Covaxin and Covishield in January 2021 , launching a nationwide vaccination drive.
The Vaccine Maitri initiative saw India export COVID-19 vaccines to multiple countries, positioning the nation as a global health partner.
The vaccine push was framed as a flagship outcome of the Atmanirbhar Bharat Abhiyan , launched in May 2020 to reduce import dependence in strategic sectors.
Singh linked the outcome directly to India's 'growing strength and strong leadership,' reflecting a recurring BJP narrative on pandemic management.
When the world was scrambling for vaccines and supply chains were collapsing, India did something remarkable — it inoculated its own citizens and then turned outward, shipping doses to nations in need. Union Textiles Minister Giriraj Singh invoked that chapter on Tuesday, September 29, 2026, posting a tribute to India's scientific capability and self-reliance during the COVID-19 pandemic.
In his post, Singh wrote: 'कोरोना के कठिन दौर में भारत ने अपनी वैज्ञानिक क्षमता और आत्मनिर्भरता का परिचय दिया' — 'In the difficult period of COVID, India demonstrated its scientific capability and self-reliance.' He noted that the country not only ensured vaccines for its own citizens but also delivered them to several nations around the world, calling it proof of India's growing strength and strong leadership.
From Covaxin to the world: the Vaccine Maitri chapter
The milestone Singh references traces back to January 2021, when India granted emergency use authorisation to both Covaxin and Covishield and launched one of the largest vaccination drives in history. Within weeks, the government moved beyond domestic supply. Under the Vaccine Maitri initiative, India began dispatching doses to dozens of countries — a diplomatic gesture that reframed the nation's global health identity from a recipient of aid to a provider of it.
The scale was significant. Neighbours, island nations, and African states received early consignments. It was soft power delivered in a cold-chain container.
Atmanirbhar Bharat's pharmaceutical test case
The vaccine story sits squarely inside the Atmanirbhar Bharat Abhiyan, the self-reliance drive launched in May 2020 as the pandemic exposed the risks of import dependence in critical sectors. Pharmaceuticals were always a centrepiece of that argument: India already supplied a large share of the world's generic medicines, and the domestic vaccine push extended that logic to biologics and emergency health response.
For BJP leaders, this sequence — domestic crisis, indigenous solution, global export — has become a recurring frame for demonstrating national capability. Singh's post fits that pattern precisely, linking scientific achievement to political leadership in a single breath.
As India continues building out its health-security infrastructure and pandemic-preparedness frameworks, the COVID vaccine chapter remains the clearest proof-of-concept the government reaches for. Whether it translates into lasting institutional capacity — not just a crisis response — is the question the next parliamentary health debate will have to answer.
Point of View
Then capability projected outward as diplomacy. The Vaccine Maitri initiative gave India a rare moment of 'donor' status in global health, and BJP leaders have consistently mined it for electoral and diplomatic messaging. Revisiting this frame in late 2026 suggests the government is keen to anchor its health-security credentials ahead of any fresh public health discussions or parliamentary sessions. The harder question the post sidesteps is whether the institutional architecture built during that emergency has since been deepened into durable pandemic preparedness.
NationPress
29 Sept 2026
Frequently Asked Questions
What is Vaccine Maitri?
Vaccine Maitri was India's initiative to export COVID-19 vaccine doses to other countries, beginning in early 2021. It involved supplying Covishield and Covaxin to dozens of nations, particularly neighbours and developing countries, as part of India's diplomatic and humanitarian outreach during the pandemic.
What did Giriraj Singh say about India's COVID vaccine response?
Giriraj Singh posted that India demonstrated its scientific capability and self-reliance during the difficult COVID period, ensuring vaccines for its own citizens while also delivering them to several other countries — which he called proof of India's growing strength and strong leadership.
What is Atmanirbhar Bharat and how does it relate to vaccines?
Atmanirbhar Bharat Abhiyan is the self-reliance initiative launched by the Indian government in May 2020, which emphasised reducing import dependence across strategic sectors including pharmaceuticals. The domestic development and large-scale production of COVID-19 vaccines was widely cited as a flagship outcome of this policy direction.
When did India approve Covaxin and Covishield?
India granted emergency use authorisation to both Covaxin, developed by Bharat Biotech, and Covishield, manufactured by the Serum Institute of India, in January 2021, after which the nationwide vaccination programme was launched.
Who is Giriraj Singh?
Giriraj Singh is a senior BJP leader and the Union Minister of Textiles in the Indian government. He is a Lok Sabha Member of Parliament representing the Begusarai constituency in Bihar.
